HKU student-athletes are getting ready for the 15th National Games in November 2025, balancing rigorous training, academic commitments, and personal challenges while HKU supports them in their quest to perform at their best!
HKU Innovation Week 2025 marks the University’s annual celebration of innovation and entrepreneurship. It showcases HKU’s success and commitment to turning visionary research into real-world impact and nurturing a vibrant culture of innovation.
HKU Information Day for Undergraduate Admissions 2025 attracted 76,000 prospective students and families. Themed ‘AI for Every Mind’, the event highlighted HKU’s innovative integration of AI across various disciplines, preparing future leaders for a technology-driven world.
Stellar results in the 2025 National Natural Science Foundation of China funding exercise highlight the exceptional calibre of HKU’s young researchers and Hong Kong’s contributions to advancing innovation.
HKU President and Vice-Chancellor Professor Xiang Zhang welcomes the Chief Executive’s 2025 Policy Address initiatives that enhance Hong Kong’s innovation potential and promote synergy among education, technology, and talent development to advance its status as a global education hub.
HKU’s new Vice-President and Pro-Vice-Chancellor (Institutional Advancement) Professor Yang Wang is a philomath who brings his global outlook, rich administrative experience and a flair for networking to his new role at HKU.
Two remarkable HKU students – Cherry Tam from the Faculty of Social Sciences and Harold Lam from the Faculty of Architecture – have been named Top 10 Outstanding Tertiary Students of Hong Kong in 2025.
HKU research reveals how ocean acidification can trigger an inherited sexual bias in oyster reproduction that could have long-term implications for their survival and coastal ecosystems.
Researchers at HKUMed have discovered that atorvastatin, traditionally a medication for cholesterol, can effectively target liver cancer cells, enhancing existing treatments and providing new hope for patients with limited treatment options.
